Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

EIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension

Eichstaedt, Christina A. ; Song, Jie ; Benjamin, Nicola ; Harutyunova, Satenik ; Fischer, Christine ; Grünig, Ekkehard ; Hinderhofer, Katrin

In: Respiratory Research, 17 (2016), Nr. 141. pp. 1-8. ISSN 1465-993X

[thumbnail of 12931_2016_Article_457.pdf]
PDF, English
Download (772kB) | Lizenz: Creative Commons LizenzvertragEIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension by Eichstaedt, Christina A. ; Song, Jie ; Benjamin, Nicola ; Harutyunova, Satenik ; Fischer, Christine ; Grünig, Ekkehard ; Hinderhofer, Katrin underlies the terms of Creative Commons Attribution 3.0 Germany

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.


Background: Mutations in the eukaryotic translation initiation factor 2α kinase 4 (EIF2AK4) gene have recently been identified in recessively inherited veno-occlusive disease. In this study we assessed if EIF2AK4 mutations occur also in a family with autosomal dominantly inherited pulmonary arterial hypertension (HPAH) and incomplete penetrance of bone morphogenic protein receptor 2 (BMPR2) mutations. Methods: Clinical examinations in a family with 10 members included physical examination, electrocardiogram, (stress)-echocardiography and lung function. Manifest PAH was confirmed by right heart catheterisation in three affected subjects. Genetic analysis was performed using a new PAH-specific gene panel analysis with next generation sequencing of all known PAH and further candidate genes. Identified variants were confirmed by Sanger sequencing. Results: All living family members with manifest HPAH carried two pathogenic heterozygous mutations: a frame shift mutation in the BMPR2 gene and a novel splice site mutation in the EIF2AK4 gene. Two family members who carried the BMPR2 mutation only did not develop manifest HPAH. Conclusions: This is the first study suggesting that EIF2AK4 can also contribute to autosomal dominantly inherited HPAH. Up to now it has only been identified in a recessive form of HPAH. Only those family members with a co-occurrence of two mutations developed manifest HPAH. Thus, the EIF2AK4 and BMRPR2 mutations support the “second hit” hypothesis explaining the variable penetrance of HPAH in this family. Hence, the assessment of all known PAH genes in families with a known mutation might assist in predictions about the clinical manifestation in so far non-affected mutation carriers.

Document type: Article
Journal or Publication Title: Respiratory Research
Volume: 17
Number: 141
Publisher: BioMed Central
Place of Publication: London
Date Deposited: 16 Nov 2016 13:13
Date: 2016
ISSN: 1465-993X
Page Range: pp. 1-8
Faculties / Institutes: Medizinische Fakultät Heidelberg > Medizinische Universitäts-Klinik und Poliklinik
Medizinische Fakultät Heidelberg > Institut für Humangenetik
Medizinische Fakultät Heidelberg > Thoraxklinik Heidelberg gGmbH
DDC-classification: 610 Medical sciences Medicine
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative